Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biosimilars market report explains the definition, types, applications, major countries, and major players of the Biosimilars market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
F Hoffmann-La Roche
Pfizer
Teva Pharmaceuticals Industries
Sandoz International GmbH
Dr Reddy’s Laboratories
Biocon
Celltrion
Samsung Bioepis
Amgen Inc
By Type:
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Peptides (Glucagon, Calcitonin)
By End-User:
Oncology
Blood Disorders
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Biosimilars Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Biosimilars Outlook to 2028- Original Forecasts
-
2.2 Biosimilars Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Biosimilars Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Biosimilars Market- Recent Developments
-
6.1 Biosimilars Market News and Developments
-
6.2 Biosimilars Market Deals Landscape
7 Biosimilars Raw Materials and Cost Structure Analysis
-
7.1 Biosimilars Key Raw Materials
-
7.2 Biosimilars Price Trend of Key Raw Materials
-
7.3 Biosimilars Key Suppliers of Raw Materials
-
7.4 Biosimilars Market Concentration Rate of Raw Materials
-
7.5 Biosimilars Cost Structure Analysis
-
7.5.1 Biosimilars Raw Materials Analysis
-
7.5.2 Biosimilars Labor Cost Analysis
-
7.5.3 Biosimilars Manufacturing Expenses Analysis
8 Global Biosimilars Import and Export Analysis (Top 10 Countries)
-
8.1 Global Biosimilars Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Biosimilars Export by Region (Top 10 Countries) (2017-2028)
9 Global Biosimilars Market Outlook by Types and Applications to 2022
-
9.1 Global Biosimilars Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Peptides (Glucagon, Calcitonin) Consumption and Growth Rate (2017-2022)
-
9.2 Global Biosimilars Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Blood Disorders Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Biosimilars Market Analysis and Outlook till 2022
-
10.1 Global Biosimilars Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Biosimilars Consumption (2017-2022)
-
10.2.2 Canada Biosimilars Consumption (2017-2022)
-
10.2.3 Mexico Biosimilars Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Biosimilars Consumption (2017-2022)
-
10.3.2 UK Biosimilars Consumption (2017-2022)
-
10.3.3 Spain Biosimilars Consumption (2017-2022)
-
10.3.4 Belgium Biosimilars Consumption (2017-2022)
-
10.3.5 France Biosimilars Consumption (2017-2022)
-
10.3.6 Italy Biosimilars Consumption (2017-2022)
-
10.3.7 Denmark Biosimilars Consumption (2017-2022)
-
10.3.8 Finland Biosimilars Consumption (2017-2022)
-
10.3.9 Norway Biosimilars Consumption (2017-2022)
-
10.3.10 Sweden Biosimilars Consumption (2017-2022)
-
10.3.11 Poland Biosimilars Consumption (2017-2022)
-
10.3.12 Russia Biosimilars Consumption (2017-2022)
-
10.3.13 Turkey Biosimilars Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Biosimilars Consumption (2017-2022)
-
10.4.2 Japan Biosimilars Consumption (2017-2022)
-
10.4.3 India Biosimilars Consumption (2017-2022)
-
10.4.4 South Korea Biosimilars Consumption (2017-2022)
-
10.4.5 Pakistan Biosimilars Consumption (2017-2022)
-
10.4.6 Bangladesh Biosimilars Consumption (2017-2022)
-
10.4.7 Indonesia Biosimilars Consumption (2017-2022)
-
10.4.8 Thailand Biosimilars Consumption (2017-2022)
-
10.4.9 Singapore Biosimilars Consumption (2017-2022)
-
10.4.10 Malaysia Biosimilars Consumption (2017-2022)
-
10.4.11 Philippines Biosimilars Consumption (2017-2022)
-
10.4.12 Vietnam Biosimilars Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Biosimilars Consumption (2017-2022)
-
10.5.2 Colombia Biosimilars Consumption (2017-2022)
-
10.5.3 Chile Biosimilars Consumption (2017-2022)
-
10.5.4 Argentina Biosimilars Consumption (2017-2022)
-
10.5.5 Venezuela Biosimilars Consumption (2017-2022)
-
10.5.6 Peru Biosimilars Consumption (2017-2022)
-
10.5.7 Puerto Rico Biosimilars Consumption (2017-2022)
-
10.5.8 Ecuador Biosimilars Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Biosimilars Consumption (2017-2022)
-
10.6.2 Kuwait Biosimilars Consumption (2017-2022)
-
10.6.3 Oman Biosimilars Consumption (2017-2022)
-
10.6.4 Qatar Biosimilars Consumption (2017-2022)
-
10.6.5 Saudi Arabia Biosimilars Consumption (2017-2022)
-
10.6.6 United Arab Emirates Biosimilars Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Biosimilars Consumption (2017-2022)
-
10.7.2 South Africa Biosimilars Consumption (2017-2022)
-
10.7.3 Egypt Biosimilars Consumption (2017-2022)
-
10.7.4 Algeria Biosimilars Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Biosimilars Consumption (2017-2022)
-
10.8.2 New Zealand Biosimilars Consumption (2017-2022)
11 Global Biosimilars Competitive Analysis
-
11.1 F Hoffmann-La Roche
-
11.1.1 F Hoffmann-La Roche Company Details
-
11.1.2 F Hoffmann-La Roche Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 F Hoffmann-La Roche Biosimilars Main Business and Markets Served
-
11.1.4 F Hoffmann-La Roche Biosimilars Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Pfizer
-
11.2.1 Pfizer Company Details
-
11.2.2 Pfizer Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Pfizer Biosimilars Main Business and Markets Served
-
11.2.4 Pfizer Biosimilars Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Teva Pharmaceuticals Industries
-
11.3.1 Teva Pharmaceuticals Industries Company Details
-
11.3.2 Teva Pharmaceuticals Industries Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Teva Pharmaceuticals Industries Biosimilars Main Business and Markets Served
-
11.3.4 Teva Pharmaceuticals Industries Biosimilars Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Sandoz International GmbH
-
11.4.1 Sandoz International GmbH Company Details
-
11.4.2 Sandoz International GmbH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Sandoz International GmbH Biosimilars Main Business and Markets Served
-
11.4.4 Sandoz International GmbH Biosimilars Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Dr Reddy’s Laboratories
-
11.5.1 Dr Reddy’s Laboratories Company Details
-
11.5.2 Dr Reddy’s Laboratories Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Dr Reddy’s Laboratories Biosimilars Main Business and Markets Served
-
11.5.4 Dr Reddy’s Laboratories Biosimilars Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Biocon
-
11.6.1 Biocon Company Details
-
11.6.2 Biocon Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Biocon Biosimilars Main Business and Markets Served
-
11.6.4 Biocon Biosimilars Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Celltrion
-
11.7.1 Celltrion Company Details
-
11.7.2 Celltrion Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Celltrion Biosimilars Main Business and Markets Served
-
11.7.4 Celltrion Biosimilars Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Samsung Bioepis
-
11.8.1 Samsung Bioepis Company Details
-
11.8.2 Samsung Bioepis Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Samsung Bioepis Biosimilars Main Business and Markets Served
-
11.8.4 Samsung Bioepis Biosimilars Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Amgen Inc
-
11.9.1 Amgen Inc Company Details
-
11.9.2 Amgen Inc Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Amgen Inc Biosimilars Main Business and Markets Served
-
11.9.4 Amgen Inc Biosimilars Product Portfolio
-
11.9.5 Recent Research and Development Strategies
12 Global Biosimilars Market Outlook by Types and Applications to 2028
-
12.1 Global Biosimilars Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Peptides (Glucagon, Calcitonin) Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Biosimilars Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Biosimilars Market Analysis and Outlook to 2028
-
13.1 Global Biosimilars Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Biosimilars Consumption Forecast (2022-2028)
-
13.2.2 Canada Biosimilars Consumption Forecast (2022-2028)
-
13.2.3 Mexico Biosimilars Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Biosimilars Consumption Forecast (2022-2028)
-
13.3.2 UK Biosimilars Consumption Forecast (2022-2028)
-
13.3.3 Spain Biosimilars Consumption Forecast (2022-2028)
-
13.3.4 Belgium Biosimilars Consumption Forecast (2022-2028)
-
13.3.5 France Biosimilars Consumption Forecast (2022-2028)
-
13.3.6 Italy Biosimilars Consumption Forecast (2022-2028)
-
13.3.7 Denmark Biosimilars Consumption Forecast (2022-2028)
-
13.3.8 Finland Biosimilars Consumption Forecast (2022-2028)
-
13.3.9 Norway Biosimilars Consumption Forecast (2022-2028)
-
13.3.10 Sweden Biosimilars Consumption Forecast (2022-2028)
-
13.3.11 Poland Biosimilars Consumption Forecast (2022-2028)
-
13.3.12 Russia Biosimilars Consumption Forecast (2022-2028)
-
13.3.13 Turkey Biosimilars Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Biosimilars Consumption Forecast (2022-2028)
-
13.4.2 Japan Biosimilars Consumption Forecast (2022-2028)
-
13.4.3 India Biosimilars Consumption Forecast (2022-2028)
-
13.4.4 South Korea Biosimilars Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Biosimilars Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Biosimilars Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Biosimilars Consumption Forecast (2022-2028)
-
13.4.8 Thailand Biosimilars Consumption Forecast (2022-2028)
-
13.4.9 Singapore Biosimilars Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Biosimilars Consumption Forecast (2022-2028)
-
13.4.11 Philippines Biosimilars Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Biosimilars Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Biosimilars Consumption Forecast (2022-2028)
-
13.5.2 Colombia Biosimilars Consumption Forecast (2022-2028)
-
13.5.3 Chile Biosimilars Consumption Forecast (2022-2028)
-
13.5.4 Argentina Biosimilars Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Biosimilars Consumption Forecast (2022-2028)
-
13.5.6 Peru Biosimilars Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Biosimilars Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Biosimilars Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Biosimilars Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Biosimilars Consumption Forecast (2022-2028)
-
13.6.3 Oman Biosimilars Consumption Forecast (2022-2028)
-
13.6.4 Qatar Biosimilars Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Biosimilars Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Biosimilars Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Biosimilars Consumption Forecast (2022-2028)
-
13.7.2 South Africa Biosimilars Consumption Forecast (2022-2028)
-
13.7.3 Egypt Biosimilars Consumption Forecast (2022-2028)
-
13.7.4 Algeria Biosimilars Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Biosimilars Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Biosimilars Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Biosimilars
-
Figure of Biosimilars Picture
-
Table Global Biosimilars Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Biosimilars Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Consumption and Growth Rate (2017-2022)
-
Figure Global Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Consumption and Growth Rate (2017-2022)
-
Figure Global Peptides (Glucagon, Calcitonin) Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Biosimilars Consumption by Country (2017-2022)
-
Table North America Biosimilars Consumption by Country (2017-2022)
-
Figure United States Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Canada Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Mexico Biosimilars Consumption and Growth Rate (2017-2022)
-
Table Europe Biosimilars Consumption by Country (2017-2022)
-
Figure Germany Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure UK Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Spain Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Belgium Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure France Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Italy Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Denmark Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Finland Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Norway Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Sweden Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Poland Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Russia Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Turkey Biosimilars Consumption and Growth Rate (2017-2022)
-
Table APAC Biosimilars Consumption by Country (2017-2022)
-
Figure China Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Japan Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure India Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure South Korea Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Thailand Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Singapore Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Philippines Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Biosimilars Consumption and Growth Rate (2017-2022)
-
Table South America Biosimilars Consumption by Country (2017-2022)
-
Figure Brazil Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Colombia Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Chile Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Argentina Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Peru Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Biosimilars Consumption and Growth Rate (2017-2022)
-
Table GCC Biosimilars Consumption by Country (2017-2022)
-
Figure Bahrain Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Oman Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Qatar Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Biosimilars Consumption and Growth Rate (2017-2022)
-
Table Africa Biosimilars Consumption by Country (2017-2022)
-
Figure Nigeria Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure South Africa Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Egypt Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Algeria Biosimilars Consumption and Growth Rate (2017-2022)
-
Table Oceania Biosimilars Consumption by Country (2017-2022)
-
Figure Australia Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Biosimilars Consumption and Growth Rate (2017-2022)
-
Table F Hoffmann-La Roche Company Details
-
Table F Hoffmann-La Roche Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Biosimilars Main Business and Markets Served
-
Table F Hoffmann-La Roche Biosimilars Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Biosimilars Main Business and Markets Served
-
Table Pfizer Biosimilars Product Portfolio
-
Table Teva Pharmaceuticals Industries Company Details
-
Table Teva Pharmaceuticals Industries Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceuticals Industries Biosimilars Main Business and Markets Served
-
Table Teva Pharmaceuticals Industries Biosimilars Product Portfolio
-
Table Sandoz International GmbH Company Details
-
Table Sandoz International GmbH Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandoz International GmbH Biosimilars Main Business and Markets Served
-
Table Sandoz International GmbH Biosimilars Product Portfolio
-
Table Dr Reddy’s Laboratories Company Details
-
Table Dr Reddy’s Laboratories Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy’s Laboratories Biosimilars Main Business and Markets Served
-
Table Dr Reddy’s Laboratories Biosimilars Product Portfolio
-
Table Biocon Company Details
-
Table Biocon Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Biosimilars Main Business and Markets Served
-
Table Biocon Biosimilars Product Portfolio
-
Table Celltrion Company Details
-
Table Celltrion Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celltrion Biosimilars Main Business and Markets Served
-
Table Celltrion Biosimilars Product Portfolio
-
Table Samsung Bioepis Company Details
-
Table Samsung Bioepis Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Samsung Bioepis Biosimilars Main Business and Markets Served
-
Table Samsung Bioepis Biosimilars Product Portfolio
-
Table Amgen Inc Company Details
-
Table Amgen Inc Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Biosimilars Main Business and Markets Served
-
Table Amgen Inc Biosimilars Product Portfolio
-
Figure Global Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peptides (Glucagon, Calcitonin) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biosimilars Consumption Forecast by Country (2022-2028)
-
Table North America Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure United States Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure Germany Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure China Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure Brazil Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure Australia Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
